Bristol Myers Squibb Co. Stock Falls Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) shed 1.95% to $71.23 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.05% to 4,119.21 and the Dow Jones Industrial Average rising 0.02% to 34,092.96. Bristol Myers Squibb Co. closed $10.21 short of its 52-week high ($81.44), which the company achieved on December 1st.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.92% to $164.92, Pfizer Inc. (PFE) fell 0.43% to $43.97, and Abbott Laboratories (ABT) rose 1.15% to $111.82. Trading volume (10.7 M) eclipsed its 50-day average volume of 8.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 1, 2023.
(END) Dow Jones Newswires
February 01, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.